George Nassif, MD
Geriatric Medicine · Clinton Twp, MINPI 1225209075
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.0% of the total across 86 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 14.6% — the pattern of someone who eats at a lot of different presentations.
Across 86 payments — averaging $23.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$291
- GSK$254
- Stryker$161
- Lilly USA, LLC$161
- Astellas Pharma US Inc$132
- Boston Scientific$126
- plus $865 from 14 others
What the payments were for
- Food & beverage$1,89095%
- Education$1005%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 15 | $291 |
| GSK | 15 | $254 |
| Stryker | 1 | $161 |
| Lilly USA, LLC | 9 | $161 |
| Astellas Pharma US Inc | 3 | $132 |
| Boston Scientific | 1 | $126 |
| Johnson & Johnson | 6 | $118 |
| Teleflex LLC | 1 | $118 |
| Sunovion Pharmaceuticals Inc. | 6 | $112 |
| Novo Nordisk | 7 | $110 |
| AbbVie(2 entities) | 5 | $108 |
| Boehringer Ingelheim | 5 | $91 |
| Novartis | 4 | $67 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $32 |
| Urovant Sciences Inc | 1 | $25 |
| Scilex Pharmaceuticals Inc. | 1 | $22 |
| AstraZeneca | 1 | $18 |
| UCB, Inc. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Nestle Healthcare Nutrition Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CLOTTRIEVER BOLD CATHETER$161
- Axonics$126
- QuikClot$118
How this compares
$1,990 in reported general payments places this provider in the 85th percentile of 168 geriatric medicine providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 402 | $229,114 |
| JardianceEmpagliflozin | 271 | $208,646 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 179 | $138,369 |
| OzempicSemaglutide | 106 | $132,966 |
| JanuviaSitagliptin Phosphate | 140 | $100,153 |
| MyrbetriqMirabegron | 181 | $91,758 |
| LinzessLinaclotide | 118 | $73,857 |
| XareltoRivaroxaban | 52 | $49,315 |
| EntrestoSacubitril/Valsartan | 63 | $36,536 |
| FarxigaDapagliflozin Propanediol | 38 | $25,199 |
| Breo ElliptaFluticasone/Vilanterol | 38 | $23,809 |
| TradjentaLinagliptin | 22 | $19,423 |
| Atorvastatin Calcium | 867 | $14,384 |
| GemtesaVibegron | 36 | $14,137 |
| Tresiba Flextouch U-100Insulin Degludec | 40 | $13,101 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $291 | $229,114402 claims |
| Boehringer IngelheimJardiance, Tradjenta | $91 | $228,069293 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $254 | $162,178217 claims |
| Novo NordiskOzempic | $110 | $132,966106 claims |
| Astellas Pharma US IncMyrbetriq | $132 | $91,758181 claims |
| AbbVieLinzess, Restasis | $108 | $79,920136 claims |
| Johnson & JohnsonXarelto | $118 | $49,31552 claims |
| NovartisEntresto | $67 | $36,53663 claims |
| AstraZenecaFarxiga | $18 | $25,19938 claims |
| Lilly USA, LLCMounjaro | $161 | $13,03913 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 168 geriatric medicine providers in Michigan.
Other geriatric medicine in Clinton Twp
- Gerald DaneshvarHamtramck$23K
- Jailan ElayoubiDearborn$20K
- Grace JenqAnn Arbor$12K
- Afriyie GrayGrand Rapids$12K
- Bnan RazokyTroy$11K
- Saket SaxenaDetroit$11K
- Randolph SchumacherFlint$9K
- Ronald BarnettLivonia$7K
- Michael BurryLivonia$7K
- Keith TobinLivonia$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.